Lifecore Biomedical (LFCR) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts LFCR Hot Sheet
Join SI Premium – FREE
Lifecore Biomedical (NASDAQ: LFCR) reported Q2 EPS of ($0.19), $0.04 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $34.17 million versus the consensus estimate of $31.66 million.
For earnings history and earnings-related data on Lifecore Biomedical (LFCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Punjab National Bank (PNB:IN) PT Raised to INR130 at Kotak
- Crompton Greaves Consumer Electricals Ltd (CROMPTON:IN) PT Lowered to INR292 at Nomura/Instinet
- Metro Brands Ltd (METROBRA:IN) PT Lowered to INR950 at Kotak
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
